XRP Adoption Expands to 6,000 US Pharmacies
Wellgistics Health incorporates XRP into its payment system across 6,000 US pharmacies, backed by a $50 million equity line from LDA Capital.
- Wellgistics Health launches XRP payments in pharmacies.
- Enhances speed, liquidity, and transparency in healthcare.
- XRP serves as payment and treasury asset.
The implementation highlights growing institutional interest in cryptocurrency, providing faster and cost-effective transactions. It marks a significant real-world application of blockchain technology in the healthcare sector.
Wellgistics Health Initiative
The initiative by Wellgistics Health, supported by a $50 million line of credit from LDA Capital, aims to transform healthcare payments with XRP’s integration. Wellgistics will use XRP to enhance payment speed and liquidity for 6,000 US pharmacies.
Brian Norton, CEO of Wellgistics Health, emphasizes the integration of blockchain technology to improve payment systems. The decision positions Wellgistics Health as a pioneering entity in healthcare, optimizing financial operations with XRP as a core asset.
“Our blockchain-enabled payment system and ledger is just the next logical step in healthcare evolution, allowing us to hardwire speed, liquidity, and transparency into a system that’s long been starved of all three.” — Brian Norton, CEO of Wellgistics Health
Implications for the Healthcare Industry
The payment transformation is expected to deliver real-time settlement, boosting efficiency in transactions between pharmacies, suppliers, and manufacturers. This move reflects growing interest in incorporating cryptocurrencies in traditional sectors.
XRP’s cost-effective framework, with less than $0.0002 per transaction, provides a stark contrast to traditional wire fees. Its integration proves advantageous for liquidity and financial control within pharmacy networks.
The broader implications could lead to increased adoption of XRP and similar technologies within the healthcare industry. While concerns regarding regulatory approval exist, the strategy could offer essential cost benefits and propel technological advances.
This initiative demonstrates how blockchain, through XRP, may continue influencing financial systems and operational efficiency. It highlights a potential shift in pharmaceutical distribution towards more scalable and agile financial frameworks.
More From Crypto News
Solana Has 3% Odds of Topping $120 This Week
A prediction market tracking Solana’s weekly price gives the token just a 3% probability of trading above $120 before the week closes, reflecting tight implied...
Bitcoin Miner Selling Pressure Eases as Revenues Rise 78%
Bitcoin miner selling pressure is easing as miner revenues post a reported 78% increase, according to CryptoPotato. The shift marks a notable change from the ag...
Ethereum Selling Pressure Builds as ETH Falls Below 50-Day SMA
Ethereum is facing renewed selling pressure after ETH slipped below its 50-day simple moving average, a technical level closely tracked by short-term traders as...
Ledger Investigates Reported $86M Crypto Drain
Ledger is reportedly investigating a crypto drain estimated at $86 million, with reseller supply-chain concerns emerging as a central question in the case. The...
NEAR Rises 10% as Bitcoin Rebounds Toward $83K
NEAR Protocol surged more than 10% on October 10, 2026, hitting $5. 25 and posting the strongest daily gain among larger-cap altcoins, as Bitcoin shook off a mu...
Ethereum ETF Approval Prediction Market: Can It Drive Demand This Week?
A new weekly prediction market on CryptoSlate is tracking where Ethereum closes by October 11, 2026, with the sub-$2,400 outcome currently leading at 15. 5%.
